Sarah Aldred

Sarah Aldred

Auto-generated profile, based on publicly available information

Sarah Aldred

School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2008 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
SBStuart Bennett
Stuart Bennett
MGMelissa M. Grant
Melissa M. Grant
SASarah Aldred
Sarah Aldred
Alzheimer's disease and vascular dementia are the two most common types of dementia with the former being the most predominant. It is evident that oxidative stress, an environment where pro-oxidant species overwhelm antioxidant species, is involved i

5 March 2022 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Open access
PDF file
CDConnor Dunleavy
Connor Dunleavy
RERichard J. Elsworthy
Richard J. Elsworthy
RURachel Upthegrove
Rachel Upthegrove
SWStephen J. Wood
Stephen J. Wood
SASarah Aldred
Sarah Aldred
Objective: To provide a comprehensive analysis of cytokine perturbations in antipsychotic‐naïve first‐episode psychosis (FEP) populations and assess the relationship between inflammatory biomarkers and negative symptom severity.Methods: A systematic review and meta‐analysis following PRISMA guidelines were conducted. A total of 1042 records were identified via systematic search of EMBASE, MEDLINE and APA PsycInfo databases. Sixteen studies met the inclusion criteria and were eligible for inclusion in the review. Ten of these studies had sufficient data for inclusion in a random effects, pooled‐effect meta‐analysis.Results: A significant and large effect size was reported for IFN‐γ, IL‐6 and IL‐12, and a moderate effect size reported for IL‐17 (p = 0.05). Regarding proinflammatory cytokines and relationships to negative symptomology, moderate positive relationships were reported for negative symptoms and IL‐1β, IL‐2, IL‐6 and TNF‐α, across four studies. For anti‐inflammatory cytokines, one strong and one weak‐to‐moderate negative relationship was described for IL‐10 and negative symptoms. Contrastingly, a strong positive relationship was reported for IL‐4 and negative symptoms.Conclusion: There is evidence of significantly elevated proinflammatory cytokines in antipsychotic‐naïve FEP populations, alongside promising findings from cohort data suggesting an interaction between inflammation and primary negative symptomology. Future studies should seek to come to a consensus on a panel of cytokines that relate most specifically to negative symptoms, and consider longitudinal studies to investigate how cytokine fluctuations may relate to exacerbation of symptoms.

1 February 2003 in Journal of Autism and Developmental Disorders
Verified
Journal Article
Closed access
PDF file
SASarah Aldred
Sarah Aldred
KMKieran M. Moore
Kieran M. Moore
MFMichael Fitzgerald
Michael Fitzgerald
RWRosemary H. Waring
Rosemary H. Waring

17 April 2015 in Journal of Sports Sciences
Verified
Journal Article
Open access
AWAlex Wadley
Alex Wadley
YCYu-Wen Chen
Yu-Wen Chen
GLGregory Y.H. Lip
Gregory Y.H. Lip
JFJames P. Fisher
James P. Fisher
SASarah Aldred
Sarah Aldred
The purpose of the present study was to compare acute changes in oxidative stress and inflammation in response to steady state and low volume, high intensity interval exercise (LV-HIIE). Untrained healthy males (n = 10, mean ± s: age 22 ± 3 years; VO2MAX 42.7 ± 5.0 ml · kg−1 · min−1) undertook three exercise bouts: a bout of LV-HIIE (10 × 1 min 90% VO2MAX intervals) and two energy-matched steady-state cycling bouts at a moderate (60% VO2MAX; 27 min, MOD) and high (80% VO2MAX; 20 min, HIGH) intensity on separate days. Markers of oxidative stress, inflammation and physiological stress were assessed before, at the end of exercise and 30 min post-exercise (post+30). At the end of all exercise bouts, significant changes in lipid hydroperoxides (LOOH) and protein carbonyls (PCs) (LOOH (nM): MOD +0.36; HIGH +3.09; LV-HIIE +5.51 and PC (nmol · mg−1 protein): MOD −0.24; HIGH −0.11; LV-HIIE −0.37) were observed. Total antioxidant capacity (TAC) increased post+30, relative to the end of all exercise bouts (TAC (µM): MOD +189; HIGH +135; LV-HIIE +102). Interleukin (IL)-6 and IL-10 increased post+30 in HIGH and LV-HIIE only (P < 0.05). HIGH caused the greatest lymphocytosis, adrenaline and cardiovascular response (P < 0.05). At a reduced energy cost and physiological stress, LV-HIIE elicited similar cytokine and oxidative stress responses to HIGH.

1 October 2004 in Dementia and Geriatric Cognitive Disorders
Verified
Journal Article
Closed access
MMaria Cristina Polidori
Maria Cristina Polidori
PMPaola Mattioli
Paola Mattioli
SASarah Aldred
Sarah Aldred
RCRoberta Cecchetti
Roberta Cecchetti
WSWilhelm Stahl
Wilhelm Stahl
Patrizia MecocciPatrizia Mecocci
Patrizia Mecocci
A large body of evidence supports a role of oxidative stress in Alzheimer disease (AD) and in cerebrovascular disease. A vascular component might be critical in the pathophysiology of AD, but there is a substantial lack of data regarding the simultaneous behavior of peripheral antioxidants and biomarkers of oxidative stress in AD and vascular dementia (VaD). Sixty-three AD patients, 23 VaD patients and 55 controls were included in the study. We measured plasma levels of water-soluble (vitamin C and uric acid) and lipophilic (vitamin E, vitamin A, carotenoids including lutein, zeaxanthin, β-cryptoxanthin, lycopene, α- and β-carotene) antioxidant micronutrients as well as levels of biomarkers of lipid peroxidation [malondialdehyde (MDA)] and of protein oxidation [immunoglobulin G (IgG) levels of protein carbonyls and dityrosine] in patients and controls. With the exception of β-carotene, all antioxidants were lower in demented patients as compared to controls. Furthermore, AD patients showed a significantly higher IgG dityrosine content as compared to controls. AD and VaD patients showed similar plasma levels of plasma antioxidants and MDA as well as a similar IgG content of protein carbonyls and dityrosine. We conclude that, independent of its nature – vascular or degenerative – dementia is associated with the depletion of a large spectrum of antioxidant micronutrients and with increased protein oxidative modification. This might be relevant to the pathophysiology of dementing disorders, particularly in light of the recently suggested importance of the vascular component in AD development.